Craig A Walker
Electrician in Salt Lake City, UT
License number
Utah 146554-5504
Issued Date
Jan 13, 1990
Expiration Date
Nov 30, 2018
Category
Electrician
Type
Journeyman Electrician
Address
Address
Salt Lake City, UT
Professional information
I-Superfamily Conotoxins
US Patent:
6767895, Jul 27, 2004
Filed:
Jun 29, 2001
Appl. No.:
09/894882
Inventors:
Craig S. Walker - Salt Lake City UT
Reshma Shetty - Salt Lake City UT
Elsie C. Jimenez - Quezon, PH
J. Michael McIntosh - Salt Lake City UT
Baldomero M. Olivera - Salt Lake City UT
Maren Watkins - Salt Lake City UT
Robert M. Jones - Salt Lake City UT
Gregory S. Shen - Salt Lake City UT
Reshma Shetty - Salt Lake City UT
Elsie C. Jimenez - Quezon, PH
J. Michael McIntosh - Salt Lake City UT
Baldomero M. Olivera - Salt Lake City UT
Maren Watkins - Salt Lake City UT
Robert M. Jones - Salt Lake City UT
Gregory S. Shen - Salt Lake City UT
Assignee:
Cognetix, Inc. - Salt Lake City UT
University of Utah Research Foundation - Salt Lake City UT
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 3816
US Classification:
514 12, 514 2, 530300, 530324
Abstract:
The invention relates to relatively short peptides (termed I-conotoxins herein), about 30-50 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which preferably include four disulfide bonds.
Conantokins
US Patent:
6515103, Feb 4, 2003
Filed:
May 11, 2000
Appl. No.:
09/142080
Inventors:
Fe C. Abogadie - London, GB
Lourdes J. Cruz - Salt Lake City UT
Baldomero M. Olivera - Salt Lake City UT
Craig Walker - Salt Lake City UT
Clark Colledge - Alpine UT
David R. Hillyard - Salt Lake City UT
Elsie Jimenez - Qyezan, PH
Richard T. Layer - Salt Lake City UT
Li-Ming Zhou - Salt Lake City UT
Gregory S. Shen - Salt Lake City UT
R. Tyler McCabe - Salt Lake City UT
Jean E. Rivier - La Jolla CA
Lourdes J. Cruz - Salt Lake City UT
Baldomero M. Olivera - Salt Lake City UT
Craig Walker - Salt Lake City UT
Clark Colledge - Alpine UT
David R. Hillyard - Salt Lake City UT
Elsie Jimenez - Qyezan, PH
Richard T. Layer - Salt Lake City UT
Li-Ming Zhou - Salt Lake City UT
Gregory S. Shen - Salt Lake City UT
R. Tyler McCabe - Salt Lake City UT
Jean E. Rivier - La Jolla CA
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
Salk Institute - LaJolla CA
Cognetix, Inc. - Salt Lake City UT
Salk Institute - LaJolla CA
International Classification:
A61K 3800
US Classification:
530326, 530300, 530327, 514 13, 514 14, 514 15, 514 21
Abstract:
The present invention is directed to conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more -carboxyglutamic acid residues. The conantokins are useful for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.
Linear Gamma-Carboxyglutamate Rich Conotoxins
US Patent:
2005015, Jul 21, 2005
Filed:
Dec 22, 2004
Appl. No.:
11/018369
Inventors:
Baldomero Olivera - Salt Lake City UT, US
J. McIntosh - Salt Lake City UT, US
James Garrett - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Robert Jones - Salt Lake City UT, US
J. McIntosh - Salt Lake City UT, US
James Garrett - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Robert Jones - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
International Classification:
C07K014/435
US Classification:
530324000, 530326000
Abstract:
The invention relates to linear γ-carboxyglutamate rich conotoxins, derivatives or pharmaceutically acceptable salts thereof, and uses thereof, including the treatment of neurologic and psychiatric disorders, such as anticonvillsant agents, as neuroprotective agents or for the management of pain. The invention further relates to nucleic acid sequences encoding the conopeptides and encoding propeptides, as well as the propeptides.
Linear Gamma-Carboxyglutamate Rich Conotoxins
US Patent:
2006024, Oct 26, 2006
Filed:
Jun 29, 2006
Appl. No.:
11/476638
Inventors:
Baldomero Olivera - Salt Lake City UT, US
J. McIntosh - Salt Lake City UT, US
James Garrett - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Robert Jones - Salt Laker City UT, US
J. McIntosh - Salt Lake City UT, US
James Garrett - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Robert Jones - Salt Laker City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
International Classification:
A61K 38/16, A61K 38/10, C07K 14/435
US Classification:
514012000, 514013000, 530324000, 530326000
Abstract:
The invention relates to linear y-carboxyglutamate rich conotoxins, derivatives or pharmaceutically acceptable salts thereof, and uses thereof, including the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, as neuroprotective agents or for the management of pain. The invention further relates to nucleic acid sequences encoding the conopeptides and encoding propeptides, as well as the propeptides.
Tau-Conotoxin Peptides
US Patent:
2005012, Jun 9, 2005
Filed:
Jul 16, 2003
Appl. No.:
10/619473
Inventors:
Craig Walker - Salt Lake City UT, US
Reshma Shetty - Salt Lake City UT, US
Baldomero Olivera - Salt Lake City UT, US
David Hooper - Salt Lake City UT, US
Richard Jacobsen - San Francisco CA, US
Doug Steel - Salt Lake City UT, US
Robert Jones - San Diego CA, US
Reshma Shetty - Salt Lake City UT, US
Baldomero Olivera - Salt Lake City UT, US
David Hooper - Salt Lake City UT, US
Richard Jacobsen - San Francisco CA, US
Doug Steel - Salt Lake City UT, US
Robert Jones - San Diego CA, US
Assignee:
The University of Utah Research Foundation - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
International Classification:
A61K038/08, C07K007/06, A61K038/14
US Classification:
514015000, 530328000, 514008000, 530322000
Abstract:
The invention relates to relatively short peptides (termed τ-conotoxins herein), about 10-25 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which preferably include two disulfide bonds.
I-Superfamily Conotoxins
US Patent:
2005009, May 5, 2005
Filed:
Jul 20, 2004
Appl. No.:
10/894314
Inventors:
Craig Walker - Salt Lake City UT, US
Reshma Shetty - Salt Lake City UT, US
Elsie Jimenez - Quezon City, PH
J. McIntosh - Salt Lake City UT, US
Baldomero Olivera - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Robert Jones - Salt Lake City UT, US
Gregory Shen - Salt Lake City UT, US
Reshma Shetty - Salt Lake City UT, US
Elsie Jimenez - Quezon City, PH
J. McIntosh - Salt Lake City UT, US
Baldomero Olivera - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Robert Jones - Salt Lake City UT, US
Gregory Shen - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
International Classification:
A61K038/16, C07K014/435
US Classification:
514012000, 530350000, 514324000
Abstract:
The invention relates to relatively short peptides (termed 1-conotoxins herein), about 30-50 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which preferably include four disulfide bonds.
Gamma-Conopeptides
US Patent:
2006022, Oct 5, 2006
Filed:
Aug 26, 2003
Appl. No.:
10/647519
Inventors:
Michael Fainzilber - Haifa, IL
Karel Kits - Amsterdam, NL
Alma Burlingame - Sausalito CA, US
Baldomero Olivera - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Reshma Shetty - Salt Lake City UT, US
Lourdes Cruz - Manila, PH
Julita Imperial - Salt Lake City UT, US
Clark Colledge - Draper UT, US
Karel Kits - Amsterdam, NL
Alma Burlingame - Sausalito CA, US
Baldomero Olivera - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Maren Watkins - Salt Lake City UT, US
Reshma Shetty - Salt Lake City UT, US
Lourdes Cruz - Manila, PH
Julita Imperial - Salt Lake City UT, US
Clark Colledge - Draper UT, US
Assignee:
Cognetix Inc. - Salt Lake City UT
University of Utah Research Foundation - Salt Lake City UT
University of Utah Research Foundation - Salt Lake City UT
International Classification:
C07K 7/08, C07K 14/435
US Classification:
530326000, 530327000, 530328000
Abstract:
This invention relates to relatively short peptides about 25-40 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogs to the naturally available peptides, and which include three cyclizing disulfide linkages and one or more γcarboxyglutamate residues. More specifically, the present invention is directed to γ-conopeptides having the general formula I: Xaa-Cys-Xaa-Cys-Xaa-Xaa-Cys-Cys-Xaa-Cys-Xaa-Cys-Xaa(SEQ ID NO:1), as described herein; or having the general formula II: Xaa-Cys-Xaa-Cys-Xaa-Xaa-Cys-Cys-Xaa-Xaa-Cys-Xaa-Cys-Xaa(SEQ ID NO:2), as defined herein; or having the general formula III: Xaa-Cys-Xaa-Cys-Xaa-Xaa-Xaa-Cys-Cys-Ser-Asn-Ser-Cys-Asp-Xaa-Cys-Xaa(SEQ ID NO:3), as described herein; or having the general formula IV: Xaa-Cys-Xaa-Cys-Xaa-Xaa-Xaa-Cys-Cys-Ser-Asn-Ser-Cys-Asp-Xaa-Cys-Xaa(SEQ ID NO:4), as described herein; or having the general formula V: Xaa-Xaa-Cys-Xaa-Xaa-Phe-Xaa-Cys-Thr-Xaa-Ser-Xaa-Cys-Cys-Ser-Asn-Ser-Cys-Asp-Gln-Thr-Tyr-Cys-Xaa-Leu-Xaa(SEQ ID NO:5), as described herein. The invention further relates to specific γ-conopeptides, specific pro-γ-conopeptides and nucleic acids encoding the pro-γ-conopeptides. The invention also includes pharmaceutically acceptable salts of the conopeptides. These conopeptides are useful as agonists of neuronal pacemaker calcium channels.
Conus Polypeptides
US Patent:
2010019, Aug 5, 2010
Filed:
Oct 16, 2009
Appl. No.:
12/580487
Inventors:
Andres Villu MARICQ - Salt Lake City UT, US
Stori JENSEN - Salt Lake City UT, US
Craig WALKER - Salt Lake City UT, US
David MADSEN - West Valley City UT, US
Baldomero OLIVERA - Salt Lake City UT, US
Michael ELLISON - Thornton CO, US
Stori JENSEN - Salt Lake City UT, US
Craig WALKER - Salt Lake City UT, US
David MADSEN - West Valley City UT, US
Baldomero OLIVERA - Salt Lake City UT, US
Michael ELLISON - Thornton CO, US
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT
International Classification:
A61K 38/14, A61K 38/17, C07K 9/00, C07K 14/435, C07H 21/04, A61P 25/28, A61P 25/00, G01N 33/68
US Classification:
514 8, 514 12, 530322, 530324, 530350, 536 235, 436 86
Abstract:
The invention relates to peptides (termed propeller peptides herein) and related peptides (termed peptides of the G12.2 family herein), about 60 to about 90 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which blocks the desensitization of AMPA-type ionotropic glutamate receptors (AMPARs).
Conantokins
US Patent:
2003019, Oct 16, 2003
Filed:
Feb 4, 2003
Appl. No.:
10/357467
Inventors:
Fe Abogadie - London, GB
Lourdes Cruz - Manila, PH
Baldomero Olivera - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Clark Colledge - Draper UT, US
David Hillyard - Salt Lake City UT, US
Elsie Jimenez - Quezon City, PH
Lourdes Cruz - Manila, PH
Baldomero Olivera - Salt Lake City UT, US
Craig Walker - Salt Lake City UT, US
Clark Colledge - Draper UT, US
David Hillyard - Salt Lake City UT, US
Elsie Jimenez - Quezon City, PH
International Classification:
C12Q001/68, C07H021/04
US Classification:
435/006000, 536/023500, 536/024300
Abstract:
The present invention is directed to conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more -carboxyglutamic acid residues. The contantokins are useful for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.
Τ-Conotoxin Peptides
US Patent:
7390785, Jun 24, 2008
Filed:
Nov 7, 2005
Appl. No.:
11/267257
Inventors:
Craig Walker - Salt Lake City UT, US
Reshma Shetty - Salt Lake City UT, US
Baldomero M. Olivera - Salt Lake City UT, US
David Hooper - Salt Lake City UT, US
Richard Jacobsen - San Francisco CA, US
Doug Steel - Salt Lake City UT, US
Robert Jones - Salt Lake City UT, US
Reshma Shetty - Salt Lake City UT, US
Baldomero M. Olivera - Salt Lake City UT, US
David Hooper - Salt Lake City UT, US
Richard Jacobsen - San Francisco CA, US
Doug Steel - Salt Lake City UT, US
Robert Jones - Salt Lake City UT, US
Assignee:
The University of Utah Research Foundation - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
Cognetix, Inc. - Salt Lake City UT
International Classification:
C07K 7/02, A61K 38/00
US Classification:
514 2, 530324, 530300, 514 12, 514 24, 514 25, 514 42
Abstract:
The invention relates to relatively short peptides (termed τ-conotoxins herein), about 10-25 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which preferably include two disulfide bonds.